Epibiotech EPI-001 Hair Regrowth Cell Therapy Update

September 5, 2023 /

Follicle Thought presents an exclusive interview with Epibiotech CEO Dr. Jong-Hyuk Sung to discuss EPI-001 trials, other alopecia pipeline candidates, and the company’s latest business developments. Epibiotech’s therapeutic pipeline, displayed above, represents the most diverse pipeline for hair loss or alopecia-related therapies in the world. In fact, Epibiotech is one of the only biotech companies…

Read More

Kintor Announces New Advanced Androgen Receptor Drug GT20029

August 21, 2023 /

China Trial Enrolls 180 Patients To Complete Enrollment (8/22/23) On August 22, 2023, Kintor Pharmaceutical announced the completion of patient enrollment in a phase 2 trial in China for GT20029. This means all of the patients needed to complete the study have been enrolled, and will undergo their dosing schedule over the next 12 weeks.…

Read More

Verteporfin Hair Transplant Surgery Trial With Dr. Bloxham

July 28, 2023 /

Seeking Scarless Hair Transplants With Donor Regeneration On July 11th, 2023, Dr. Blake Bloxham completed a verteporfin trial in his New York office. The trial focused on testing verteporfin’s effect on minimizing scarring or potentially producing scarless healing during a hair transplant procedure. Dr. Bloxham treated three different patients undergoing FUT (Follicular Unit Transplantation) hair…

Read More

Allogeneic “Off The Shelf” PRP For Hair Loss 2023: Carmell Therapeutics

July 25, 2023 /

A Pennsylvania-based biotech is seeking to reinvent one of the most discussed mainstream hair growth procedures, platelet rich plasma therapy. Carmell Therapeutics Plasma-based Bioactive Material It’s a thought that has crossed the minds of many people who have heard of, or received, PRP injections for hair growth – “can’t they make a version of PRP…

Read More

Mallia Therapeutics Secures Funding For Hair Growth Drug CD83

July 11, 2023 /

The German biotech startup Mallia Therapeutics (formerly MalliaBiotech) has secured seed funding to further its hair loss drug soluble CD83. CD83 Hair Growth Through Immune Modulation On July 11, 2023, Mallia Therapeutics issued a press release announcing a successful seed financing round and the presentation of data at a European Hair Research Society (EHRS) meeting.…

Read More

AI Discovers New Hair Loss Drug: LCH34

July 3, 2023 /

Life Code shares poster from the 25th World Congress of Dermatology Singapore 2023 with Follicle Thought. Artificial Intelligence Small Molecule Enhanced Hair Growth Follicle Thought is pleased to share an exclusive look at Life Code’s poster from the current World Congress of Dermatology event. Just over a year ago, I shared an introduction to Life…

Read More

Amplifica Begins Trial For AMP-303

June 28, 2023 /

On June 28, 2023, Amplifica Holdings Group announced the initiation of a clinical trial for one of its lead candidate molecules from the study of hairy moles. Amplifica’s AMP-303 has officially entered a clinical trial. According to a news release on the company’s website and PR Newswire, the first patient was dosed in a multicenter,…

Read More

StimuSIL’s SAGA-001: A New Paradigm in Laser Therapy for Hair Loss

June 19, 2023 /

Follicle Thought is pleased to announce a new company developing a treatment for androgenetic alopecia with an innovative technology. Unlike most other biotechs tackling the challenging field of hair regeneration, StimuSIL is a biomedical device company. Their team has created a completely new way to deliver photobiomodulation and incorporated it into a proprietary, patented hair…

Read More

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.